Use of vecuronium in the management of tetanus.
A case of tetanus sufficiently severe to require treatment with neuromuscular blocking drugs and controlled ventilation is described. The use of an infusion of vecuronium helped to minimise the cardiovascular disturbances which accompanied the disease and permitted rapid spontaneous reversal of neuromuscular blockade when the infusion was stopped.
Powles
A B
AB
Ganta
R
R
D005260:Female; D006801:Humans; D008875:Middle Aged; D009466:Neuromuscular Blocking Agents / Q000627:therapeutic use*; D010197:Pancuronium / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012121:Respiration, Artificial; D013742:Tetanus / Q000628:therapy*; D014673:Vecuronium Bromide
D009466:Neuromuscular Blocking Agents; D014673:Vecuronium Bromide; D010197:Pancuronium